Brightonix Imaging specializes in manufacturing biomedical imaging services for the clinical and preclinical healthcare sector. Their product offerings include:

Brain-dedicated PETs.
SiPM-based small animal MRI systems for hybrid imaging and standalone use.
Automated quantification software for amyloid-β PET.

Brightonix Imaging aims to empower clinicians with advanced biomedical devices, enabling efficient medical operations and improved patient care.

Series A funding of $4.73 million in May 2022